FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paul Warrener

Research Profile

Living Beings

Concepts & Ideas

Molecular Sequence Data

Chemicals & Drugs

Procedures

Physiology

Microbial Drug Resistance

Anatomy

Co-author Network

Publications

TOP 3
Brett K Kaiser; David Lawson; Cameron Miller; Srinivas Mullapudi; Patricia Navarro; Angel Paredes; Mark Budde; Michael Carleton; Fred Cross; Jason W Hickman; Paul Warrener; James M Roberts
Fatty aldehydes in cyanobacteria are a metabolically flexible precursor for a diversity of biofuel products.
Antonio DiGiandomenico; Sandrine Guillard; Melissa Hamilton; Lutz Jermutus; Ashley Elaine Keller; Jia Lin; Randall S Macgill; Michael P McCarthy; David A Melnick; Ralph Minter; Peter Ravn; JoAnn A Suzich; Mladen Tomich; Vignesh Venkatraman; Qun Wang; Paul Warrener; Jessica C Bonnell; Maria Margarita Camara; C Kendall Stover
Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening.
Paul Warrener; Sybil M G Williams; Matt Biery; Michele A Cleary; Marcia Gordon; Sammy Kim; Peter S Linsley; Carlo Toniatti; Michael Carleton
Synthetic lethality of PARP inhibition in BRCA-network disrupted tumor cells is associated with interferon pathway activation and enhanced by interferon-γ.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paul Warrener (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Brett K Kaiser; David Lawson; Cameron Miller; Srinivas Mullapudi; Patricia Navarro; Angel Paredes; Mark Budde; Michael Carleton; Fred Cross; Jason W Hickman; Paul Warrener; James M Roberts
Fatty aldehydes in cyanobacteria are a metabolically flexible precursor for a diversity of biofuel products.
PloS one 2013;8(3):e58307.
2012: Antonio DiGiandomenico; Sandrine Guillard; Melissa Hamilton; Lutz Jermutus; Ashley Elaine Keller; Jia Lin; Randall S Macgill; Michael P McCarthy; David A Melnick; Ralph Minter; Peter Ravn; JoAnn A Suzich; Mladen Tomich; Vignesh Venkatraman; Qun Wang; Paul Warrener; Jessica C Bonnell; Maria Margarita Camara; C Kendall Stover
Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening.
The Journal of experimental medicine 2012;209(7):1273-87.
2012: Paul Warrener; Sybil M G Williams; Matt Biery; Michele A Cleary; Marcia Gordon; Sammy Kim; Peter S Linsley; Carlo Toniatti; Michael Carleton
Synthetic lethality of PARP inhibition in BRCA-network disrupted tumor cells is associated with interferon pathway activation and enhanced by interferon-γ.
Apoptosis : an international journal on programmed cell death 2012;17(7):691-701.
2009: B Nelson Chau; Robert L Diaz; Matthew A Saunders; Chun Cheng; Aaron N Chang; Paul Warrener; Jeffrey Bradshaw; Peter Linsley; Michele A Cleary
Identification of SULF2 as a novel transcriptional target of p53 by use of integrated genomic analyses.
Cancer research 2009;69(4):1368-74.
2006: Steven Bartz; Zhan Zhang; Julja Burchard; Maki Imakura; Melissa Martin; Anthony Palmieri; Rachel Needham; Jie Guo; Marcia Gordon; Namjin Chung; Paul Warrener; Aimee L Jackson; Michael Carleton; Melissa Oatley; Louis Locco; Francesca Santini; Todd Smith; Priya Kunapuli; Marc Ferrer; Berta Strulovici; Stephen H Friend; Peter Linsley
Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptions.
Molecular and cellular biology 2006;26(24):9377-86.
2006: Khisimuzi Mdluli; Pamela R Witte; Toni Kline; Adam W Barb; Alice L Erwin; Bryce E Mansfield; Amanda McClerren; Michael C Pirrung; L Nathan Tumey; Paul Warrener; Christian R H Raetz; C Kendall Stover
Molecular validation of LpxC as an antibacterial drug target in Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy 2006;50(6):2178-84.
2006: Michael Carleton; Mao Mao; Matthew Biery; Paul Warrener; Sammy Kim; Carolyn Buser; C Gary Marshall; Christine Fernandes; James Annis; Peter Linsley
RNA interference-mediated silencing of mitotic kinesin KIF14 disrupts cell cycle progression and induces cytokinesis failure.
Molecular and cellular biology 2006;26(10):3853-63.
2005: William R Schwan; Paul Warrener; Elizabeth Keunz; C Kendall Stover; Kim Folger
Mutations in the cueA gene encoding a copper homeostasis P-type ATPase reduce the pathogenicity of Pseudomonas aeruginosa in mice.
International journal of medical microbiology : IJMM 2005;295(4):237-42.
2001: Fiona S L Brinkman; EL Macfarlane; Paul Warrener; Robert E W Hancock
Evolutionary relationships among virulence-associated histidine kinases.
Infection and immunity 2001;69(8):5207-11.
2000: C Kendall Stover; X Q Pham; Alice L Erwin; S D Mizoguchi; Paul Warrener; M J Hickey; F S Brinkman; W O Hufnagle; D J Kowalik; M Lagrou; R L Garber; L Goltry; E Tolentino; S Westbrock-Wadman; Y Yuan; Linnea Brody; S N Coulter; K R Folger; A Kas; K Larbig; R Lim; K Smith; D Spencer; G K Wong; Z Wu; Ian Paulsen; J Reizer; M H Saier; R E Hancock; S Lory; M V Olson
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen.
Nature 2000;406(6799):959-64.
2000: C Kendall Stover; Paul Warrener; D R VanDevanter; emily glenn; T M Arain; Michael H Langhorne; S W Anderson; J A Towell; Y Yuan; D N McMurray; B N Kreiswirth; Clifton E Barry; W R Baker
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis.
Nature 2000;405(6789):962-6.
2000: Toni Kline; M Fromhold; T E McKennon; S Cai; J Treiberg; N Ihle; D Sherman; William R Schwan; Mark J Hickey; Paul Warrener; Pamela R Witte; Linnea Brody; L Goltry; L M Barker; S U Anderson; S K Tanaka; Ribhi Shawar; L Y Nguyen; Michael H Langhorne; A Bigelow; L Embuscado; E Naeemi
Antimicrobial effects of novel siderophores linked to beta-lactam antibiotics.
Bioorganic & medicinal chemistry 2000;8(1):73-93.
1999: S Westbrock-Wadman; emily glenn; Mark J Hickey; SN Coulter; Y Q Zhu; Paul Warrener; L Y Nguyen; Ribhi Shawar; Kim Folger ; C Kendall Stover
Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability.
Antimicrobial agents and chemotherapy 1999;43(12):2975-83.
1996: D R VanDevanter; Paul Warrener; L Bennett; Emily R Schultz; SN Coulter; R L Garber; Timothy M Rose
Detection and analysis of diverse herpesviral species by consensus primer PCR.
Journal of clinical microbiology 1996;34(7):1666-71.
1995: Paul Warrener; Marc S Collett
Pestivirus NS3 (p80) protein possesses RNA helicase activity.
Journal of virology 1995;69(3):1720-6.
1993: JoAnn A Suzich; James K Tamura; Frances J Palmer-Hill; Paul Warrener; Arash Grakoui; Charles M Rice; Stephen M Feinstone; Marc S Collett
Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes.
Journal of virology 1993;67(10):6152-8.
1993: James K Tamura; Paul Warrener; Marc S Collett
RNA-stimulated NTPase activity associated with the p80 protein of the pestivirus bovine viral diarrhea virus.
Virology 1993;193(1):1-10.
1993: Paul Warrener; James K Tamura; Marc S Collett
RNA-stimulated NTPase activity associated with yellow fever virus NS3 protein expressed in bacteria.
Journal of virology 1993;67(2):989-96.
1992: Stephen Rosenfeld; K Yoshimoto; Sachiko Kajigaya; S Anderson; Neal S Young; A Field; Paul Warrener; Geetha P Bansal; Marc S Collett
Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface.
The Journal of clinical investigation 1992;89(6):2023-9.
1991: Paul Warrener; RA Petryshyn
Phosphorylation and proteolytic degradation of nucleolin from 3T3-F442A cells.
Biochemical and biophysical research communications 1991;180(2):716-23.